A functional polymorphism in XRCC1 is associated with glioma risk: Evidence from a meta-analysis

Molecular Biology Reports

Volumn 40, Issue 1, 2013, Pages 567-572

  Wei, Xiangtai ^a   Chen, Duo ^a   Lv, Tao ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Glioma; Meta analysis; Susceptibility; XRCC 1

Indexed keywords

ARGININE; GLYCINE; XRCC1 PROTEIN;

ARTICLE; CAUCASIAN; DNA DAMAGE; DNA REPAIR; GENE FUNCTION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GLIOMA; HUMAN; META ANALYSIS; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

DNA-BINDING PROTEINS; GENETIC PREDISPOSITION TO DISEASE; GLIOMA; HUMANS; ODDS RATIO; POLYMORPHISM, GENETIC; POPULATION GROUPS; PUBLICATION BIAS; RISK;

EID: 84871273761     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2093-y     Document Type: Article

References (36)

1. Ricard D, Idbaih A, Ducray F et al (2012) Primary brain tumours in adults. Lancet 379:1984-1996
2. Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359:492-507
3. Schwartzbaum JA, Fisher JL, Aldape KD et al (2006) Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2:494-503; quiz 491 p following 516
4. Tewari R, Choudhury SR, Mehta VS et al (2012) TNFalpha regulates the localization of CD40 in lipid rafts of glioma cells. Mol Biol Rep 39:8695-8699
5. Shete S, Hosking FJ, Robertson LB et al (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41:899-904
6. Gu J, Liu Y, Kyritsis AP et al (2009) Molecular epidemiology of primary brain tumors. Neurotherapeutics 6:427-435
7. Caldecott KW (2003) XRCC1 and DNA strand break repair. DNA Repair (Amst) 2:955-969
8. Horton JK, Watson M, Stefanick DF et al (2008) XRCC1 and DNA polymerase beta in cellular protection against cytotoxic DNA single-strand breaks. Cell Res 18:48-63
9. Goode EL, Ulrich CM, Potter JD (2002) Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11:1513-1530
10. Thompson LH, West MG (2000) XRCC1 keeps DNA from getting stranded. Mutat Res 459:1-18
11. Ginsberg G, Angle K, Guyton K et al (2011) Polymorphism in the DNA repair enzyme XRCC1: utility of current database and implications for human health risk assessment. Mutat Res 727:1-15
12. Hu Z, Ma H, Chen F et al (2005) XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev 14:1810-1818
13. Dai L, Duan F, Wang P et al (2012) XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case-control studies. Mol Biol Rep 39:9535-9547
14. Berhane N, Sobti RC, Mahdi SA (2012) DNA repair genes polymorphism (XPG and XRCC1) and association of prostate cancer in a north Indian population. Mol Biol Rep 39:2471-2479
15. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101-129
16. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
17. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188
18. Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634
19. Cengiz SL, Acar H, Inan Z et al (2008) Deoxy-ribonucleic acid repair genes XRCC1 and XPD polymorphisms and brain tumor risk. Neurosciences (Riyadh) 13:227-232
20. Custodio AC, Almeida LO, Pinto GR et al (2011) Analysis of the polymorphisms XRCC1Arg194Trp and XRCC1Arg399Gln in gliomas. Genet Mol Res 10:1120-1129
21. Felini MJ, Olshan AF, Schroeder JC et al (2007) DNA repair polymorphisms XRCC1 and MGMT and risk of adult gliomas. Neuroepidemiology 29:55-58
22. Hu XB, Feng Z, Fan YC et al (2011) Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to glioma. Asian Pac J Cancer Prev 12:2981-2984
23. Kiuru A, Lindholm C, Heinavaara S et al (2008) XRCC1 and XRCC3 variants and risk of glioma and meningioma. J Neurooncol 88:135-142
24. Liu JM, Sun H, Huang LW et al (2011) Relationship between XRCC 1 polymorphisms and adult gliomas. Mod Prev Med 38:3340-3341
25. Liu Y, Scheurer ME, El-Zein R et al (2009) Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev 18:204-214
26. Rajaraman P, Hutchinson A, Wichner S et al (2010) DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncol 12:37-48
27. Wang LE, Bondy ML, Shen H et al (2004) Polymorphisms of DNA repair genes and risk of glioma. Cancer Res 64:5560-5563
28. Yosunkaya E, Kucukyuruk B, Onaran I et al (2010) Glioma risk associates with polymorphisms of DNA repair genes, XRCC1 and PARP1. Br J Neurosurg 24:561-565
29. Zhou LQ, Ma Z, Shi XF et al (2011) Polymorphisms of DNA repair gene XRCC1 and risk of glioma: a case-control study in Southern China. Asian Pac J Cancer Prev 12:2547-2550
30. Sanai N, Alvarez-Buylla A, Berger MS (2005) Neural stem cells and the origin of gliomas. N Engl J Med 353:811-822
31. Liu Y, Shete S, Hosking F et al (2010) Genetic advances in glioma: susceptibility genes and networks. Curr Opin Genet Dev 20:239-244
32. Huang Y, Li L, Yu L (2009) XRCC1 Arg399Gln, Arg194Trp and Arg280His polymorphisms in breast cancer risk: a meta-analysis. Mutagenesis 24:331-339
33. Liu F, Li B, Wei Y et al (2011) XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis. Liver Int 31:802-809
34. Butkiewicz D, Rusin M, Sikora B et al (2011) An association between DNA repair gene polymorphisms and survival in patients with resected non-small cell lung cancer. Mol Biol Rep 38:5231-5241
35. Chen B, Zhou Y, Yang P et al (2012) Polymorphisms of XRCC1 and gastric cancer susceptibility: a meta-analysis. Mol Biol Rep 39:1305-1313
36. Wang B, Wang D, Huang G et al (2010) XRCC1 polymorphisms and risk of colorectal cancer: a meta-analysis. Int J Colorectal Dis 25:313-321